Cancer is the second largest disease throughout the world with an increasing mortality rate
over the past few years. The patient's survival rate is uncertain due to the limitations of …

Pancreatic cancer is the fourth most common cause of cancer-related deaths in the United
States, with over 38000 deaths in 2013. The opportunity to detect pancreatic cancer while it …

Late diagnosis contributes to pancreatic cancer (PaCa) dismal prognosis, urging for reliable,
early detection. Serum‐exosome protein and/or miRNA markers might be suitable …

The detection of rare circulating tumor cells (CTCs) in the blood of cancer patients has the
potential to be a powerful and noninvasive method for examining metastasis, evaluating …

Lung cancer is undoubtedly one of the most serious health issues of the 21 st century. It is
the second leading cause of cancer-related deaths in both men and women worldwide …

Hepatocellular carcinoma (HCC), the most common primary malignancy of the liver,
represents 1 of the leading causes of cancer deaths in the world with an estimated 21,670 …

Pancreatobiliary tract cancer is a highly fatal cancer. Detection of pancreatobiliary tract
cancer is difficult because it lacks typical clinical symptoms and because of its anatomical …

Cancer is one of the major public health issues in the world. It has become the second
leading cause of death, with approximately 75% of cancer deaths transpiring in low-or …

Background The incidence of cholangiocarcinoma has doubled over the last 15 years with a
similar rise in mortality, which provides the impetus for standardization of evidence-based …

Pancreatic cancer (PC) has posed a great health threat to a growing number of people all
over the world. Detection of serum miRNAs, being sensitive, noninvasive, and easy to …